Gaerolwe R. Masheto
Gaerolwe R. Masheto publishes mostly in Infectious Diseases, Emergency Medicine and Virology, on topics such as HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions and HIV-related health complications and treatments.
- World rank
- #1,059,322 of 7,710,434 ranked researchers
- Rank in Botswana
- #71 of 859
- Works
- 44
- Citations
- 1.4k
- Citations per work
- 32.1
What does Gaerolwe R. Masheto research?
Gaerolwe R. Masheto's work is mostly in Medicine (72%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3272.3%
- Medicine3272.3%
- Everything else817.4%
- Life Sciences510.3%
- 1Infectious Diseases43% of their works
- 2Emergency Medicine12% of their works
- 3Virology10% of their works
- 4Public Health, Environmental and Occupational Health7% of their works
- 5Surgery6% of their works
- 6Obstetrics and Gynecology5% of their works
Research topics
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- HIV-related health complications and treatments
- HIV Research and Treatment
- Tuberculosis Research and Epidemiology
- Diagnosis and treatment of tuberculosis
- Pregnancy and Medication Impact
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Gaerolwe R. Masheto's research?
The keywords of their largest research topics: Antiretroviral Therapy, HIV Infection, Drug Resistance, Integrase Inhibitors, Nucleoside Analogues, HIV Transmission, Preexposure Prophylaxis and Immune Response.
- Pneumonia
- Pregnancy
- Diagnostic Challenges
- Tuberculosis
- Treatment
- Antibodies
- Inflammation
- HIV
- Immune Response
- HIV Transmission
- Integrase Inhibitors
- HIV Infection
- Antiretroviral Therapy
- Drug Resistance
- Nucleoside Analogues
- Preexposure Prophylaxis
- Vaccine
- Cardiovascular Disease
- AIDS
- Diagnosis
- Mycobacterium tuberculosis
- Abdominal Tuberculosis
- Medication Use
- Pneumocystis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Antiretroviral Therapy765 topics
- HIV Infection382 topics
- Drug Resistance312 topics
- Integrase Inhibitors231 topic
- Nucleoside Analogues231 topic
- HIV Transmission221 topic
- Preexposure Prophylaxis221 topic
- Immune Response212 topics
- Vaccine212 topics
- HIV162 topics
- Cardiovascular Disease151 topic
- Inflammation151 topic
- AIDS131 topic
- Antibodies131 topic
- Diagnosis112 topics
- Treatment112 topics
- Mycobacterium tuberculosis81 topic
- Tuberculosis81 topic
- Abdominal Tuberculosis61 topic
- Diagnostic Challenges61 topic
- Medication Use51 topic
- Pregnancy51 topic
- Pneumocystis31 topic
- Pneumonia31 topic
Where does Gaerolwe R. Masheto work?
Gaerolwe R. Masheto's main affiliation in the publication record is Botswana Harvard AIDS Institute Partnership, Botswana.
How many publications and citations does Gaerolwe R. Masheto have?
OpenAlex counts 44 works and 1,412 citations for Gaerolwe R. Masheto, an h-index of 13, ranking #1,059,322 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gaerolwe R. Masheto. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.